Narrative Update • Jul 20
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 22, 2026
DataAggregated Company Financials
Companies6
- 7D4.7%
- 3M-21.3%
- 1Y-22.6%
- YTDn/a
Over the last 7 days, the Drug Retail industry has risen 4.7%, driven by gains from JD Health International of 4.7%. During this same period, the Dingdang Health Technology Group underperformed, falling 5.4%. In contrast, the industry has lost 23% in the last 12 months. As for the next few years, earnings are expected to grow by 15% per annum.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 23 Jul 2026 | HK$199.4b | HK$143.3b | HK$8.7b | 31.1x | 22.9x | 1.4x |
| Sat, 20 Jun 2026 | HK$185.4b | HK$143.2b | HK$8.7b | 30.8x | 21.3x | 1.3x |
| Mon, 18 May 2026 | HK$238.8b | HK$142.2b | HK$8.7b | 40x | 27.6x | 1.7x |
| Wed, 15 Apr 2026 | HK$255.4b | HK$140.7b | HK$8.6b | 45.2x | 29.5x | 1.8x |
| Fri, 13 Mar 2026 | HK$273.0b | HK$139.8b | HK$7.7b | 37.5x | 35.3x | 2x |
| Sun, 08 Feb 2026 | HK$324.9b | HK$128.8b | HK$6.9b | 45.4x | 47.1x | 2.5x |
| Tue, 06 Jan 2026 | HK$313.1b | HK$127.6b | HK$6.8b | 40x | 45.8x | 2.5x |
| Thu, 04 Dec 2025 | HK$317.9b | HK$126.1b | HK$6.8b | 41x | 47.1x | 2.5x |
| Sat, 01 Nov 2025 | HK$325.6b | HK$122.3b | HK$6.1b | 59.7x | 53x | 2.7x |
| Mon, 29 Sep 2025 | HK$354.1b | HK$122.1b | HK$6.1b | 64.1x | 57.7x | 2.9x |
| Wed, 27 Aug 2025 | HK$355.7b | HK$121.8b | HK$5.2b | 58.7x | 68.1x | 2.9x |
| Fri, 25 Jul 2025 | HK$264.7b | HK$115.8b | HK$4.5b | 49.8x | 58.6x | 2.3x |
| Sun, 22 Jun 2025 | HK$222.7b | HK$115.4b | HK$4.5b | 44.5x | 49.4x | 1.9x |
| Tue, 20 May 2025 | HK$233.4b | HK$112.0b | HK$4.2b | 63.4x | 55.3x | 2.1x |
| Thu, 17 Apr 2025 | HK$209.4b | HK$109.7b | HK$4.1b | 56.6x | 50.6x | 1.9x |
| Sat, 15 Mar 2025 | HK$218.1b | HK$108.3b | HK$5.4b | 67x | 40.5x | 2x |
| Mon, 10 Feb 2025 | HK$183.0b | HK$103.9b | HK$3.6b | 42.4x | 50.9x | 1.8x |
| Wed, 08 Jan 2025 | HK$152.3b | HK$103.1b | HK$3.6b | 36.3x | 42.7x | 1.5x |
| Fri, 06 Dec 2024 | HK$168.0b | HK$104.1b | HK$3.6b | 38x | 46.6x | 1.6x |
| Sun, 03 Nov 2024 | HK$168.3b | HK$104.7b | HK$3.3b | 47.8x | 50.7x | 1.6x |
| Tue, 01 Oct 2024 | HK$219.6b | HK$106.2b | HK$3.4b | 63.2x | 65.2x | 2.1x |
| Thu, 29 Aug 2024 | HK$133.9b | HK$104.9b | HK$3.3b | 36.2x | 40.2x | 1.3x |
| Sat, 27 Jul 2024 | HK$137.3b | HK$102.0b | HK$2.4b | 41.9x | 57.4x | 1.3x |
| Mon, 24 Jun 2024 | HK$150.3b | HK$101.9b | HK$2.4b | 45.8x | 62.9x | 1.5x |
| Wed, 22 May 2024 | HK$161.0b | HK$103.5b | HK$2.3b | 48x | 69.3x | 1.6x |
| Fri, 19 Apr 2024 | HK$134.0b | HK$103.9b | HK$2.3b | 40.1x | 57.5x | 1.3x |
| Sun, 17 Mar 2024 | HK$172.2b | HK$105.1b | -HK$1,455,897,791.00 | 56.8x | -118.2x | 1.6x |
| Tue, 13 Feb 2024 | HK$158.7b | HK$105.1b | -HK$1,455,902,314.95 | 52.1x | -109x | 1.5x |
| Thu, 11 Jan 2024 | HK$176.7b | HK$105.4b | -HK$1,460,962,691.00 | 54.9x | -121x | 1.7x |
| Sat, 09 Dec 2023 | HK$204.2b | HK$105.4b | -HK$1,461,015,765.00 | 63.8x | -139.8x | 1.9x |
| Mon, 06 Nov 2023 | HK$214.6b | HK$101.9b | -HK$1,738,060,785.00 | 89.6x | -123.5x | 2.1x |
| Wed, 04 Oct 2023 | HK$230.3b | HK$102.5b | -HK$1,677,814,747.00 | 102.8x | -137.3x | 2.2x |
| Fri, 01 Sep 2023 | HK$231.8b | HK$102.8b | -HK$1,681,776,858.00 | 73.5x | -137.8x | 2.3x |
| Sun, 30 Jul 2023 | HK$294.3b | HK$96.4b | -HK$4,184,004,618.00 | 129.5x | -70.3x | 3.1x |
Price to Earnings Ratio
-70.3x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 22.9x which is lower than its 3-year average PE of 98.8x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 2.31% | |
| Consumer Staples | 3.78% | |
| Food and Staples Retail | 2.77% | |
| Drug Retail | 4.69% | |
| Big Box Super Stores | 13.85% | |
| Food Distributors | 1.70% | |
| Food Retail | -1.15% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 241 Alibaba Health Information Technology | HK$3.40 | 1.2% +HK$646.6m | -28.6% | PE24.5x | |
| 6618 JD Health International | HK$37.68 | 0.4% +HK$510.3m | -22.7% | PE19.3x | |
| 1833 Ping An Healthcare and Technology | HK$7.55 | 1.3% +HK$212.7m | -19.9% | PE36.5x | |
| 2290 Lung Fung Group Holdings | HK$3.99 | 8.7% +HK$160.0m | n/a | PE11.7x |